{"id":38756,"date":"2025-11-09T12:12:34","date_gmt":"2025-11-09T12:12:34","guid":{"rendered":"https:\/\/allonlinebanglanewspapers.com\/news\/mltx-class-reminder-moonlake-immunotherapeutics-investors-with-losses-may-have-been-affected-by-fraud-contact-bfa-law-by-december-15-legal-deadline\/"},"modified":"2025-11-09T12:12:34","modified_gmt":"2025-11-09T12:12:34","slug":"mltx-class-reminder-moonlake-immunotherapeutics-investors-with-losses-may-have-been-affected-by-fraud-contact-bfa-law-by-december-15-legal-deadline","status":"publish","type":"post","link":"https:\/\/allonlinebanglanewspapers.com\/news\/mltx-class-reminder-moonlake-immunotherapeutics-investors-with-losses-may-have-been-affected-by-fraud-contact-bfa-law-by-december-15-legal-deadline\/","title":{"rendered":"MLTX CLASS REMINDER: MoonLake Immunotherapeutics Investors with Losses May have been Affected by Fraud \u2013 Contact BFA Law by December 15 Legal Deadline"},"content":{"rendered":"
\n

NEW YORK, Nov. 09, 2025 (GLOBE NEWSWIRE) — Leading securities law firm\u00a0Bleichmar Fonti & Auld LLP<\/strong><\/a> announces that a lawsuit has been filed against MoonLake Immunotherapeutics (NASDAQ: MLTX) and certain of the Company\u2019s senior executives for potential violations of the federal securities laws.<\/p>\n

If you invested in MoonLake, you are encouraged to obtain additional information by visiting: https:\/\/www.bfalaw.com\/cases\/moonlake-immunotherapeutics-class-action-lawsuit<\/strong><\/a>.<\/p>\n

Investors have until December 15, 2025, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in MoonLake common stock. The case is pending in the U.S. District Court for the Southern District of New York and is captioned Peters v. MoonLake Immunotherapeutics, et al.<\/em>, No. 1:25-cv-08612.<\/p>\n

Why Was MoonLake Sued for Securities Fraud?<\/strong><\/p>\n

MoonLake is a clinical-stage biotechnology company focused on developing therapies for inflammatory diseases. During the relevant period, MoonLake conducted highly anticipated Phase 3 VELA trials for sonelokimab (\u201cSLK\u201d), an investigational therapeutic designed to treat adult participants with moderate to severe hidradenitis suppurativa (\u201cHS\u201d).<\/p>\n

MoonLake told investors that its \u201cstrong clinical data,\u201d including results from its Phase 2 MIRA trial, translate into \u201chigher clinical responses for patients, and provide ample opportunity for differentiation of sonelokimab versus all competitors.\u201d The Company also stated that SLK\u2019s Nanobody structure differed in beneficial ways from traditional monoclonal antibody treatments from its competitors.<\/p>\n

As alleged, in truth, the Company\u2019s clinical data and Nanobody structure did not confer a superior clinical benefit over its competitors, calling into question the drug\u2019s chances for regulatory approval and commercial viability.<\/p>\n

The Stock Declines as the Truth Is Revealed<\/strong><\/p>\n

On September 28, 2025, MoonLake reported its week 16 results of the VELA Phase 3 trials. The Company reported disappointing results for both trials, with VELA-2 failing to meet its primary endpoint, calling into question the drug\u2019s chances for regulatory approval and commercial viability. On this news, the price of MoonLake stock fell $55.75 per share, or nearly 90%, from $61.99 per share on September 26, 2025, to $6.24 per share on September 29, 2025, the following trading day.<\/p>\n

Click here for more information: <\/strong>https:\/\/www.bfalaw.com\/cases\/moonlake-immunotherapeutics-class-action-lawsuit<\/strong><\/a>.<\/strong><\/p>\n

What Can You Do?<\/strong><\/p>\n

If you invested in MoonLake you may have legal options and are encouraged to submit your information to the firm.<\/p>\n

All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.<\/p>\n

Submit your information by visiting:<\/strong><\/p>\n

https:\/\/www.bfalaw.com\/cases\/moonlake-immunotherapeutics-class-action-lawsuit<\/strong><\/a><\/p>\n

Or contact:
Ross Shikowitz
ross@bfalaw.com<\/a>
212.789.3619<\/p>\n

Why Bleichmar Fonti & Auld LLP?<\/strong><\/p>\n

BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA<\/em>, The Legal 500<\/em>, and ISS SCAS<\/em>, and its attorneys have been named \u201cElite Trial Lawyers\u201d by the National Law Journal<\/em>, among the top \u201c500 Leading Plaintiff Financial Lawyers\u201d by Lawdragon<\/em>, \u201cTitans of the Plaintiffs\u2019 Bar\u201d by Law360<\/em> and \u201cSuperLawyers\u201d by Thomson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.\u2019s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.<\/p>\n

For more information about BFA and its attorneys, please visit https:\/\/www.bfalaw.com<\/a>.<\/p>\n

https:\/\/www.bfalaw.com\/cases\/moonlake-immunotherapeutics-class-action-lawsuit<\/strong><\/a><\/p>\n

Attorney advertising. Past results do not guarantee future outcomes.<\/em><\/p>\n

\n <\/div>\n","protected":false},"excerpt":{"rendered":"

NEW YORK, Nov. 09, 2025 (GLOBE NEWSWIRE) — Leading securities law firm\u00a0Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against MoonLake Immunotherapeutics (NASDAQ: MLTX) and certain of the Company\u2019s senior executives for potential violations of the federal securities laws. If you invested in MoonLake, you are encouraged to obtain additional information […]<\/p>\n","protected":false},"author":2,"featured_media":38757,"comment_status":"","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"fifu_image_url":"https:\/\/ml.globenewswire.com\/Resource\/Download\/44a256cf-d470-4d8a-af6b-dbb1b5bbb11e","fifu_image_alt":"","footnotes":""},"categories":[11],"tags":[],"class_list":["post-38756","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-globenewswire"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/allonlinebanglanewspapers.com\/news\/wp-json\/wp\/v2\/posts\/38756","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/allonlinebanglanewspapers.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/allonlinebanglanewspapers.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/allonlinebanglanewspapers.com\/news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/allonlinebanglanewspapers.com\/news\/wp-json\/wp\/v2\/comments?post=38756"}],"version-history":[{"count":0,"href":"https:\/\/allonlinebanglanewspapers.com\/news\/wp-json\/wp\/v2\/posts\/38756\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/allonlinebanglanewspapers.com\/news\/wp-json\/wp\/v2\/media\/38757"}],"wp:attachment":[{"href":"https:\/\/allonlinebanglanewspapers.com\/news\/wp-json\/wp\/v2\/media?parent=38756"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/allonlinebanglanewspapers.com\/news\/wp-json\/wp\/v2\/categories?post=38756"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/allonlinebanglanewspapers.com\/news\/wp-json\/wp\/v2\/tags?post=38756"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}